RecruitingNot ApplicableNCT07073378

BCI@Home: Brain Computer Interface Solutions to Enable Youth Living With Severe Disabilities


Sponsor

University of Calgary

Enrollment

18 participants

Start Date

Nov 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this trial is to evaluate use of brain computer interfaces (BCI) at home for children with severe severe physical disabilities. The main questions it aims to answer are: 1. Can a home BCI program enable children with disabilities to achieve personalized life participation goals? 2. Can a home BCI program promote implementation reach?


Eligibility

Min Age: 5 YearsMax Age: 18 Years

Inclusion Criteria6

  • Age 5-18 years
  • Severe motor impairment including inability to walk and minimal functional hand use, and/or;
  • Severe communication impairment
  • Ability to follow simple instructions and attend to simple tasks
  • Home environment suitable for the program based on clinician and family discussion;
  • Informed assent/consent

Exclusion Criteria3

  • Epileptic encephalopathy
  • Unstable epilepsy, or
  • Brain imaging incompatible with BCI functionality

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEBrain computer interface

Families will first complete an in-person visit to review available activities, set their first goals, and learn to use BCI independently. A BCI "kit" will be given to each family, with a headset and the equipment and software required to pursue their identified goals. Following this, families will participate in 12 virtual sessions over 3-6 months. Scheduling will be flexible to accommodate complex family needs. Daily online support will be provided via a messaging application. Participants who choose to continue using BCI beyond 12 sessions will be provided kits and supported.


Locations(2)

Alberta Children's Hospital

Calgary, Alberta, Canada

Glenrose Rehabilitation Hospital

Edmonton, Alberta, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07073378


Related Trials